Dr. Su Li specializes in the precision diagnosis and treatment of hematologic malignancies, including multiple myeloma, lymphoma, and leukemia. He has extensive clinical experience in hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy, providing comprehensive care across the full treatment continuum—from pre-treatment evaluation and peri-treatment management to long-term follow-up. Dr. Li has particular expertise in managing transplant-related pulmonary complications and is proficient in performing bronchoalveolar lavage (BAL), offering crucial support for high-risk and critically ill patients. His clinical work reflects deep professional strength in the management of complex hematologic diseases and high-difficulty transplant cases.
In scientific research, Dr. Li continually advances integrated clinical and translational work in leukemia, myeloma, and cellular immunotherapy. He has contributed to the refinement and innovation of treatment paradigms through ongoing, systematic exploration. His research has been published in professional journals, and he has conducted forward-looking studies in optimizing CAR-T therapeutic strategies. Dr. Li’s achievements have been presented at international academic forums, underscoring his professional expertise and growing influence in hematologic malignancies and cellular immune therapy.
